AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

20 recruiting trials

for Myopia, Child Myopia Progression

Effect of MiYOSMART iQ Spectacle Lenses on Myopia Progression in Children NCT07387159NA1 site๐Ÿ“ Moscow Hoya Lens Rus LLC ยท Tests: MiYOSMART iQ spectacle lenses A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children NCT06305663NA11 sites๐Ÿ“ Beijing๐Ÿ“ Dongcheng๐Ÿ“ Xiamen Bausch & Lomb Incorporated ยท Tests: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic), CooperVision MiSight (omafilcon A/60%) Myopia Control oโ€ฆ Pharmacological and Non-pharmacological Treatment Effects on Children With Different Predicted Myopia Progression Rate NCT06282848NA1 site๐Ÿ“ Hong Kong The Hong Kong Polytechnic University ยท Tests: Atropine 0.05%, DIMS lens Study to Evaluate the Efficacy of Alleanceยฎ (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children. NCT06389110Phase 31 site๐Ÿ“ Mexico City Laboratorios Sophia S.A de C.V. ยท Tests: Alleanceยฎ, Placebo Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses NCT07229352NA1 site๐Ÿ“ Glendale SightGlass Vision, Inc. ยท Tests: Novel spectacle lens design, Spectacle lenses A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control NCT07095894Phase 318 sites๐Ÿ“ Birmingham๐Ÿ“ Tucson๐Ÿ“ Fullerton Jaeb Center for Health Research ยท Tests: Atropine, Spectacles with HAL, Placebo Eyedrops Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses NCT07021560NA1 site๐Ÿ“ Hanoi ZEISS Vision Care ยท Tests: ZEISS MyoCare spectacle lenses, ZEISS SV RX SPH 1.5, ZEISS Clearview Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children NCT06742268n/a5 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Hwaseong-si S-Alpha Therapeutics, Inc. ยท Tests: Single vision spectacles Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years NCT07462897NA1 site๐Ÿ“ Paris Essilor International ยท Tests: MCL1, MCL2 Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY) NCT07028827Phase 311 sites๐Ÿ“ Tirana๐Ÿ“ Bari๐Ÿ“ Milan Ocus Innovation Ireland Limited ยท Tests: 0.05% atropine eye drops, 0.025% atropine eye drops, placebo eye drops Guangke Lenses in Congenital Cataract NCT07778797NA1 site๐Ÿ“ Shanghai Eye & ENT Hospital of Fudan University ยท Tests: Conventional Bifocal Lenses, Individually Customized Bifocal + Defocus Lenses Atropine in the Treatment of Myopia Study in Malaysia NCT07329777Phase 32 sites๐Ÿ“ Kuala Lumpur๐Ÿ“ Kuala Lumpur IDB VisionCare SDN BHD ยท Tests: Low dose atropine sulfate eye drops, Placebo A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children NCT06151587Phase 31 site๐Ÿ“ Wenzhou Qilu Pharmaceutical Co., Ltd. ยท Tests: QLM3004 Concentration 1, QLM3004 Concentration 2, QLM3004 Concentration 3, Placebo Electronic Spectacles Versus Low Dose Atropine in Young Myopes NCT06034379NA1 site๐Ÿ“ Hsinchu Kubota Vision Inc. ยท Tests: eSpectacle Clinical prototype (CP1) device, 0.01% atropine Factors Influencing Physiological Hyperopia in Children NCT06498947n/a1 site๐Ÿ“ Beijing Beijing Tongren Hospital ยท Tests: This study was observational with no intervention. Inhibition of Myopia Progression With Optical Devices NCT07698977n/a1 site๐Ÿ“ Budapest Semmelweis University ยท Tests: Wearing myopia-control D.I.M.S. glasses while awake, DIMS (Defocus Incorporated Multiple Segments) lenses Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens NCT06034327NA14 sites๐Ÿ“ Oakland๐Ÿ“ San Diego๐Ÿ“ San Francisco SightGlass Vision, Inc. ยท Tests: Single vision, impact-resistant spectacle lenses; Test Arm, Single vision, impact-resistant spectacle lenses; Control Aโ€ฆ Association of Genetic Variants With Myopia NCT07030153n/a2 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing Visionly Plus Eye Hospital ยท Tests: Oral swab DNA analyzed for myopia-related gene variants Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression NCT07323251NA1 site๐Ÿ“ Beijing Beijing Tongren Hospital ยท Tests: Diverse Segments Defocus Optimization (D.S.D.O.) spectacle lenses The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression NCT06708156Phase 325 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Xuancheng Oupushifang Pharmaceutical Technology Co., Ltd. ยท Tests: Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy